HAVAR Files S-1/A for $180M IPO, Details SPAC Structure & Sponsor Stakes

Ticker: HAVAR · Form: S-1/A · Filed: Sep 3, 2025 · CIK: 2042460

Harvard Ave Acquistion Corp S-1/A Filing Summary
FieldDetail
CompanyHarvard Ave Acquistion Corp (HAVAR)
Form TypeS-1/A
Filed DateSep 3, 2025
Risk Levelhigh
Pages14
Reading Time17 min
Key Dollar Amounts$180,000,000, $10.00, $0.0001, $100,000, $5,000,001
Sentimentbearish

Sentiment: bearish

Topics: SPAC, IPO, Blank Check Company, Dilution Risk, Sponsor Equity, SEC Filing, Capital Markets

Related Tickers: HAVAR

TL;DR

**HAVAR's S-1/A reveals a standard SPAC setup with significant sponsor ownership and potential dilution for public investors, making it a high-risk bet on management's ability to find a lucrative deal.**

AI Summary

Harvard Ave Acquisition Corporation (HAVAR) filed an S-1/A on September 3, 2025, for an initial public offering of 18,000,000 units at $10.00 per unit, aiming to raise $180,000,000. Each unit comprises one Class A ordinary share and one right to receive one-tenth (1/10) of a Class A ordinary share upon business combination. The company, a blank check entity, has 18 months (extendable to 24 months) to complete a business combination. Sponsors Copley Square LLC and Northlake Partner Ltd. collectively own 6,900,000 Class B ordinary shares, which will convert to Class A shares, subject to anti-dilution adjustments that could dilute public shareholders. Additionally, sponsors will purchase 339,964 private placement units and 1,019,892 restricted Class A ordinary shares for an aggregate of $3,399,640 in a separate private placement. Public shareholders have redemption rights for their Class A shares at a per-share price from the Trust Account, subject to limitations, including maintaining net tangible assets of $5,000,001.

Why It Matters

This S-1/A filing signals Harvard Ave Acquisition Corp.'s intent to raise $180 million, providing a new SPAC vehicle for investors seeking exposure to a future, yet-to-be-identified target company. The detailed ownership structure, particularly the 25% ownership by initial shareholders and potential anti-dilution adjustments, is crucial for investors to understand potential dilution. The competitive landscape for SPACs remains robust, and HAVAR's ability to identify a compelling target within its 18-24 month window will dictate its success against other blank check companies. Employees and customers of a future target company will be impacted by the strategic direction and capital infusion this SPAC brings.

Risk Assessment

Risk Level: high — The risk level is high due to the blank check nature of the company, meaning no target business has been identified, and the significant potential for dilution. The filing explicitly states, 'Our public shareholders may incur material dilution due to such anti-dilution adjustments that result in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion or additional Class B ordinary shares.' Additionally, the sponsors' nominal purchase price for insider shares and private placement units, totaling $3,399,640, compared to the $180,000,000 public offering, creates a substantial disparity in cost basis.

Analyst Insight

Investors should approach HAVAR with caution, recognizing it as a speculative investment in management's ability to execute a successful business combination. Due diligence on the management team's track record and the terms of the anti-dilution provisions is critical. Consider the 18-24 month timeline for a business combination as a key factor in your investment horizon.

Financial Highlights

debt To Equity
0.0
revenue
$0
operating Margin
N/A
total Assets
N/A
total Debt
$0
net Income
$0
eps
$0.00
gross Margin
N/A
cash Position
N/A
revenue Growth
N/A

Key Numbers

  • $180,000,000 — Total IPO Offering (Targeted capital raise from 18,000,000 units at $10.00 each)
  • 18,000,000 — Units Offered (Number of units in the initial public offering)
  • $10.00 — Price Per Unit (Offering price for each unit in the IPO)
  • 6,900,000 — Insider Shares Owned by Sponsors (Class B ordinary shares held by initial shareholders prior to the offering)
  • 2,700,000 — Over-allotment Option Units (Additional units D. Boral Capital has an option to purchase)
  • 18 — Months to Consummate Business Combination (Initial period to complete a business combination, extendable to 24 months)
  • $5,000,001 — Minimum Net Tangible Assets (Required net tangible assets to consummate an initial business combination)
  • 339,964 — Private Placement Units (Units sponsors will purchase in a separate private placement)
  • 1,019,892 — Restricted Class A Ordinary Shares (Shares sponsors will purchase in a separate private placement)
  • $3,399,640 — Aggregate Private Placement Purchase Price (Total amount paid by sponsors for private placement units and restricted Class A shares)

Key Players & Entities

  • Harvard Ave Acquisition Corporation (company) — Registrant for S-1/A filing
  • Sung Hyuk Lee (person) — Chief Executive Officer and Director of Harvard Ave Acquisition Corporation
  • Hoon Ji Choi (person) — CFO and Director of Harvard Ave Acquisition Corporation
  • Copley Square LLC (company) — Sponsor of Harvard Ave Acquisition Corporation
  • Northlake Partner Ltd. (company) — Sponsor of Harvard Ave Acquisition Corporation
  • D. Boral Capital (company) — Representative of the underwriters for the offering
  • Continental Stock Transfer & Trust Company, LLC (company) — Trustee for the Trust Account
  • Hongbo Xing (person) — Sole director and manager of Copley Square Sponsor Limited, managing member of Copley Square LLC
  • Tian Wang (person) — Sole member and sole director of Northlake Partner Ltd.
  • SEC (regulator) — Securities and Exchange Commission

FAQ

What is Harvard Ave Acquisition Corporation's primary business purpose?

Harvard Ave Acquisition Corporation is a blank check company incorporated in the Cayman Islands. Its primary purpose is to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities, without limiting its efforts to a particular industry or geographic region.

How much capital does Harvard Ave Acquisition Corporation aim to raise in its IPO?

Harvard Ave Acquisition Corporation aims to raise $180,000,000 in its initial public offering. This is based on offering 18,000,000 units at a price of $10.00 per unit.

What does each unit in the Harvard Ave Acquisition Corporation IPO consist of?

Each unit offered by Harvard Ave Acquisition Corporation consists of one Class A ordinary share, with a par value of $0.0001, and one right to receive one-tenth (1/10) of one Class A ordinary share upon the consummation of a business combination.

Who are the sponsors of Harvard Ave Acquisition Corporation and what is their initial ownership?

The two sponsors of Harvard Ave Acquisition Corporation are Copley Square LLC and Northlake Partner Ltd. Prior to the offering, they collectively own 6,900,000 Class B ordinary shares, which represent 25% of the total ordinary shares outstanding upon completion of the offering.

What is the deadline for Harvard Ave Acquisition Corporation to complete a business combination?

Harvard Ave Acquisition Corporation has 18 months from the closing of its initial public offering to consummate its initial business combination. This period can be extended by up to an additional 6 months, making the maximum period 24 months.

What are the redemption rights for public shareholders of Harvard Ave Acquisition Corporation?

Public shareholders have the opportunity to redeem their public shares upon the consummation of an initial business combination at a per-share price equal to the aggregate amount in the Trust Account, including interest (net of taxes and up to $100,000 for dissolution expenses). However, there are limitations, such as a shareholder group being restricted from redeeming more than 15% of the shares sold in the offering, and the company must maintain net tangible assets of $5,000,001.

How do the insider shares held by sponsors convert into Class A ordinary shares?

The insider shares (Class B ordinary shares) held by sponsors will automatically convert into Class A ordinary shares at the time of the initial business combination, or earlier at the holder's option, on a one-for-one basis. This conversion is subject to anti-dilution adjustments to maintain the initial shareholders' ownership at 25% of the total ordinary shares outstanding upon completion of the offering, plus shares issued in connection with the business combination.

What is the potential for dilution for public shareholders in Harvard Ave Acquisition Corporation?

Public shareholders may incur material dilution due to anti-dilution adjustments. If additional Class A ordinary shares or equity-linked securities are issued in excess of the IPO amounts and related to the business combination, the conversion ratio for Class B shares will adjust, potentially leading to Class A shares being issued on a greater than one-to-one basis upon conversion, or additional Class B ordinary shares being issued.

What is the role of the Copley non-managing members in Harvard Ave Acquisition Corporation?

Certain institutional investors, referred to as 'Copley non-managing members,' have expressed interest in purchasing non-managing membership interests in Copley Square LLC. This reflects indirect interests in 157,446 private placement units and 314,892 restricted Class A ordinary shares, as well as 1,417,014 insider shares, at a nominal purchase price.

What happens if Harvard Ave Acquisition Corporation fails to complete a business combination within the specified timeframe?

If Harvard Ave Acquisition Corporation is unable to complete its initial business combination within the specified time period (18-24 months), it will distribute the aggregate amount then on deposit in the Trust Account, including interest (net of taxes and dissolution expenses), pro rata to its public shareholders by redeeming 100% of the public shares. The company would then cease all operations except for winding up its affairs.

Risk Factors

  • Redemption Rights Impact Business Combination [high — financial]: A significant number of public shareholders may exercise their redemption rights, potentially reducing the available capital for a business combination. This could prevent HAVAR from consummating its most desirable acquisition or optimizing its capital structure, as the company must maintain net tangible assets of at least $5,000,001.
  • Sponsor Dilution from Class B Shares [medium — financial]: The 6,900,000 Class B ordinary shares held by sponsors are convertible to Class A shares, subject to anti-dilution adjustments. These adjustments could lead to further dilution for public shareholders, impacting their ownership percentage and potential returns.
  • Limited Time to Complete Business Combination [medium — financial]: HAVAR has an initial 18-month period, extendable to 24 months, to identify and complete a business combination. Failure to do so will result in the liquidation of the company and distribution of trust account assets, posing a risk to investors if a suitable target is not found within the timeframe.
  • Potential Excise Tax on Redemptions [low — regulatory]: The company notes that proceeds in the trust account are not intended to be used to pay for potential excise taxes, including those under the Inflation Reduction Act of 2022, on redemptions or stock buybacks. This could reduce the net proceeds available to shareholders upon redemption.
  • Blank Check Company Structure Risks [high — operational]: As a blank check company, HAVAR has no operating history or established business. The success of the investment is entirely dependent on the management's ability to identify and execute a successful business combination within the specified timeframe.
  • Private Placement Dilution [medium — financial]: Sponsors will purchase 339,964 private placement units and 1,019,892 restricted Class A ordinary shares for $3,399,640. While this provides capital, it also represents an additional layer of potential dilution for public shareholders.
  • Over-allotment Option [low — market]: Underwriters have an option to purchase up to an additional 2,700,000 units to cover over-allotments. If exercised, this would increase the total number of units outstanding, potentially diluting existing shareholders.
  • Limitations on Redemption Rights [medium — legal]: Shareholders holding 15% or more of the shares sold in the offering are restricted from redeeming their shares if they are acting as a group. This limitation could affect the liquidity and redemption flexibility for certain large shareholders.

Industry Context

Harvard Ave Acquisition Corporation operates within the Special Purpose Acquisition Company (SPAC) sector. This sector has seen significant activity but also faces increasing scrutiny regarding deal quality and shareholder returns. The competitive landscape for identifying attractive target businesses is intense, with numerous SPACs vying for suitable acquisition candidates. Regulatory changes and market sentiment can significantly impact the success rate and valuation of SPAC-led mergers.

Regulatory Implications

As a Cayman Islands incorporated entity, HAVAR is subject to the regulations of its domicile and the U.S. securities laws governing its IPO and potential business combination. The company must comply with SEC reporting requirements and adhere to rules regarding shareholder redemptions and disclosures. Potential future regulations, such as excise taxes on certain corporate transactions, could also impact the company's financial structure and shareholder value.

What Investors Should Do

  1. Carefully review the anti-dilution provisions related to Class B shares, as these could significantly impact the effective ownership stake of public shareholders post-combination.
  2. Assess the likelihood of HAVAR identifying and successfully completing a business combination within the 18-24 month timeframe, considering the competitive SPAC market.
  3. Understand the limitations on redemption rights, particularly for shareholders who might be considered part of a 'group', to ensure clarity on their ability to exit their investment.
  4. Evaluate the potential impact of sponsor private placement purchases on overall dilution and the alignment of sponsor incentives with public shareholders.
  5. Monitor the company's progress in identifying a target business and the terms of any proposed business combination, paying close attention to valuation and deal structure.

Key Dates

  • 2025-09-03: Filing of S-1/A Amendment No. 2 — Indicates progress in the IPO registration process, providing updated information to potential investors.

Glossary

Blank Check Company
A company formed with the sole purpose of raising capital through an initial public offering (IPO) to acquire or merge with an existing company, often referred to as a 'target business'. (HAVAR is a blank check company, meaning its entire business model is based on finding and completing a business combination.)
Units
A security that combines two or more different types of securities, typically a share of common stock and a warrant or right to purchase additional shares. (HAVAR is offering units, each consisting of one Class A ordinary share and one right to receive one-tenth of a Class A ordinary share.)
Rights
A type of security that gives the holder the option to purchase additional shares of stock at a specified price within a certain timeframe. (Each unit includes a right that entitles the holder to receive 1/10th of a Class A ordinary share upon a business combination.)
Class B Ordinary Shares
A class of shares typically held by founders or sponsors, often with different voting rights or conversion privileges compared to Class A shares. (Sponsors hold 6,900,000 Class B ordinary shares, which are convertible into Class A ordinary shares.)
Trust Account
A segregated account where funds raised from an IPO by a blank check company are held until a business combination is completed or the company liquidates. (Proceeds from the IPO are placed in a trust account, from which public shareholders can redeem their shares.)
Redemption Rights
The right of shareholders to sell their shares back to the company at a specified price, typically at the time of a business combination or upon liquidation. (Public shareholders have the right to redeem their Class A ordinary shares upon the consummation of HAVAR's initial business combination.)
Business Combination
The merger, acquisition, share exchange, or other similar transaction through which a blank check company combines with a target business. (HAVAR has a limited timeframe to identify and complete a business combination.)
Anti-dilution Adjustments
Provisions in a security's terms that protect the holder from a decrease in the value of their investment due to the issuance of new shares at a lower price. (These adjustments can affect the conversion of Class B shares and potentially dilute public shareholders.)

Year-Over-Year Comparison

This is an S-1/A filing, representing an amendment to the initial registration statement. As such, it provides updated details and disclosures rather than year-over-year financial performance comparisons. Key metrics like revenue, net income, and margins are not applicable at this pre-IPO stage for a blank check company. The focus is on the offering structure, risks, and the company's mandate to find a business combination.

Filing Stats: 4,154 words · 17 min read · ~14 pages · Grade level 20 · Accepted 2025-09-03 14:14:38

Key Financial Figures

  • $180,000,000 — 00a0; September 3, 2025 $180,000,000 Harvard Ave Acquisition Corporation
  • $10.00 — nit that we are offering has a price of $10.00 and consists of one Class A ordinary sh
  • $0.0001 — ass A ordinary share, of a par value of $0.0001 each, or “Class A ordinar
  • $100,000 — nterest (net of taxes payable and up to $100,000 of interest released to us to pay disso
  • $5,000,001 — cannot maintain net tangible assets of $5,000,001 upon such business combination, we may
  • $3,399,640 — 1d;) for an aggregate purchase price of $3,399,640 (whether or not the underwriters&#x2019
  • $207,000,000 — t the time of closing, $180,000,000 (or $207,000,000 if the underwriters exercise their over

Filing Documents

From the Filing

As filed with the Securities and Exchange Commission on September 3, 2025 . Registration No. 333-284826 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________ Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 _____________________________________ Harvard Ave Acquisition Corporation (Exact name of registrant as specified in its constitutional documents) _____________________________________ Not Applicable (Translation of Registrant’s name into English) _____________________________________ Cayman Islands   6770   Not Applicable (State or other jurisdiction of incorporation or organization)   (Primary Standard Industrial Classification Code Number)   (I.R.S. Employer Identification Number) 3 rd Floor, 166 Yongsan Yeongdengpo-gu , Seoul, 07362 +82-10-8781-0823 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) _____________________________________ Sung Hyuk Lee Chief Executive Officer 3 rd Floor, 166 Yongsan Yeongdengpo-gu , Seoul, 07362, Republic of Korea +82-10-8781-0823 (Name, address, including zip code, and telephone number, including area code, of agent for service) _____________________________________ Copies to: Arila E. Zhou, Esq. Ze’-ev D. Eiger, Esq. Robinson & Cole LLP Chrysler East Building 666 Third Avenue, 20 th Floor New York, NY 10017 Tel: (212) 451-2908   Michael J. Blankenship, Esq. Winston & Strawn LLP 800 Capitol Street, Suite 2400 Houston, TX 77002 Tel: (713) 651 -2600 _____________________________________ Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post -effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post -effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non -accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b -2 of the Exchange Act. Large accelerated filer     Accelerated filer   Non-accelerated filer     Smaller reporting company           Emerging growth company   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.   Table of Contents The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where t

View Full Filing

View this S-1/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.